Novel tumor necrosis factor toxic effects: Pulmonary hemorrhage and severe hepatic dysfunction

P. J. Schilling, J. L. Murray, Avi Markowitz

    Research output: Contribution to journalArticle

    36 Scopus citations

    Abstract

    Recombinant human tumor necrosis factor is an investigational antitumor agent currently undergoing clinical trials. Previous reports of pulmonary and hepatic toxicities include mild reversible decline in pulmonary diffusing capacity and mild elevation of bilirubin and transaminases. This report describes two novel toxicities in patients receiving their first intravenous dose of tumor necrosis factor: pulmonary hemorrhage and severe hepatic dysfunction. These patients received no other antitumor therapy for at least 4 weeks before tumor necrosis factor treatment and no additional antitumor therapy concomitant with tumor necrosis factor. An analysis of the possible pathogenesis is presented.

    Original languageEnglish (US)
    Pages (from-to)256-260
    Number of pages5
    JournalCancer
    Volume69
    Issue number1
    StatePublished - 1992

      Fingerprint

    ASJC Scopus subject areas

    • Cancer Research
    • Oncology

    Cite this

    Schilling, P. J., Murray, J. L., & Markowitz, A. (1992). Novel tumor necrosis factor toxic effects: Pulmonary hemorrhage and severe hepatic dysfunction. Cancer, 69(1), 256-260.